Psychedelic Research

While the use of psychedelic substances dates back to ancient times, research into their effects and uses was effectively shut down until recently. LSD was first discovered in 1943, and a significant interest developed in the potential psychotherapeutic uses of it and other psychedelic drugs; however, with the rise of the 1960s counterculture movement and its adaptation of psychedelics as an act of rebellion against society, the drugs were deemed dangerous, made illegal, and effectively banned from research. Modern researchers are once again delving into their potential benefits in treating a multitude of issues—from anxiety, depression, and PTSD, to brain injury and even the fear of death associated with terminal cancer.

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

Psilocybin Sessions: Psychedelics Could Help People with Addiction and Anxiety

Study participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less.

'60 Minutes' Segment Explores Psychedelics Research at Johns Hopkins

Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.

New Studies Just Found Psychedelics Help Terminal Cancer Patients and Could Be the New Wonder Drugs for Psychiatry – They Shouldn't Be Ignored

The active ingredient in magic mushrooms was given to terminal cancer patients: 80 per cent had immediate reductions in anxiety and depression which persisted for six months or longer.


Psychedelic-Assisted Therapy